- Home
- CYBN vs MIO Comparison
CYBN vs MIO Comparison
Compare CYBN & MIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYBN
- MIO
- Stock Information
- Founded
- CYBN 2019
- MIO 2021
- Country
- CYBN Canada
- MIO United States
- Employees
- CYBN N/A
- MIO N/A
- Industry
- CYBN Pharmaceuticals and Biotechnology
- MIO Investment Managers
- Sector
- CYBN Health Care
- MIO Finance
- Exchange
- CYBN Nasdaq
- MIO Nasdaq
- Market Cap
- CYBN 207.5M
- MIO 207.7M
- IPO Year
- CYBN N/A
- MIO N/A
- Fundamental
- Price
- CYBN $9.42
- MIO $12.00
- Analyst Decision
- CYBN Strong Buy
- MIO
- Analyst Count
- CYBN 3
- MIO 0
- Target Price
- CYBN $138.00
- MIO N/A
- AVG Volume (30 Days)
- CYBN 314.1K
- MIO 46.0K
- Earning Date
- CYBN 02-12-2025
- MIO 01-01-0001
- Dividend Yield
- CYBN N/A
- MIO 4.57%
- EPS Growth
- CYBN N/A
- MIO N/A
- EPS
- CYBN N/A
- MIO N/A
- Revenue
- CYBN N/A
- MIO N/A
- Revenue This Year
- CYBN N/A
- MIO N/A
- Revenue Next Year
- CYBN N/A
- MIO N/A
- P/E Ratio
- CYBN N/A
- MIO N/A
- Revenue Growth
- CYBN N/A
- MIO N/A
- 52 Week Low
- CYBN $6.50
- MIO $9.18
- 52 Week High
- CYBN $19.84
- MIO $11.36
- Technical
- Relative Strength Index (RSI)
- CYBN 40.07
- MIO 36.01
- Support Level
- CYBN $9.50
- MIO $12.02
- Resistance Level
- CYBN $10.06
- MIO $12.26
- Average True Range (ATR)
- CYBN 0.57
- MIO 0.11
- MACD
- CYBN -0.13
- MIO -0.03
- Stochastic Oscillator
- CYBN 11.44
- MIO 10.64
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.
About MIO Pioneer Municipal High Income Opportunities Fund Inc.
Pioneer Municipal High Income Opportunities Fund Inc. is a diversified, closed-end management investment company. The Fund's primary investment objective is to provide holders of the Fund's common stock with a high level of current income exempt from regular federal income tax.